J J Guillosson

Author PubWeight™ 22.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Effects of postoperative autotransfusion in prosthetic surgery of the hip with the ConstaVac device]. Ann Fr Anesth Reanim 1993 1.39
2 Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes. J Clin Invest 1994 1.29
3 c-Kit and c-kit mutations in mastocytosis and other hematological diseases. J Leukoc Biol 2000 1.12
4 Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy 2001 1.11
5 IgE-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes: the role of cAMP and nitric oxide. Cell Mol Biol (Noisy-le-grand) 1994 1.07
6 Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. Eur J Immunol 1990 0.98
7 Mast cells as a source and target for nitric oxide. Int Immunopharmacol 2001 0.92
8 Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3',5'-monophosphate-dependent mechanism. J Immunol 1997 0.91
9 Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 2001 0.90
10 Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol 1997 0.89
11 Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995 0.88
12 Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J Allergy Clin Immunol 2001 0.87
13 Nitric oxide pathway is induced by Fc epsilon RI and up-regulated by stem cell factor in mouse mast cells. Eur J Immunol 1997 0.86
14 Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 1999 0.84
15 Involvement of cyclic nucleotides in the immunomodulatory effects of nitric oxide on murine mast cells. Biochem Biophys Res Commun 1995 0.82
16 Inhibition of mouse mast cell proliferation and proinflammatory mediator release by benzodiazepines. Immunopharmacology 1999 0.81
17 Hemodynamic and metabolic effects of morphine in the critically ill. Circulation 1981 0.81
18 Haematological effects of postoperative autotransfusion in spinal surgery. Acta Anaesthesiol Scand 1994 0.80
19 Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide. Cancer Res 2001 0.79
20 [Determination of total iodine and hormonal iodine in the blood serum by use of an autoanalyzer]. Ann Biol Clin (Paris) 1966 0.78
21 Differentiation of human mast cells from bone-marrow and cord-blood progenitor cells by factors produced by a mouse stromal cell line. Ann N Y Acad Sci 1994 0.78
22 Early steps of replication of moloney murine leukemia virus in resting lymphocytes. Virology 1999 0.78
23 Specific ligation of the HIV-1 viral envelope protein gp120 on human CD34+ bone marrow-derived progenitors. Cell Mol Biol (Noisy-le-grand) 1994 0.76
24 Histamine-releasing activity of endogenous peptides on mast cells derived from different sites and species. Int Arch Allergy Appl Immunol 1989 0.76
25 Purification of normal human bone-marrow-derived basophils. Int Arch Allergy Immunol 1993 0.76
26 [Peritoneal fluid colony stimulating activity (CSA) release after Escherichia coli endotoxin infection (author's transl)]. Ann Pharm Fr 1981 0.75
27 [Demonstration of growth activity toward a granulomonocytic cell line (colony-stimulating activity) in the blood of C57Bl mice after injection of anti-theta antilymphocyte serum]. Ann Pharm Fr 1982 0.75
28 [Serum pseudocholinesterases. Preliminary study]. Anesth Analg (Paris) 1975 0.75
29 [The role of endogenous cortisol in the production of CSA (colony stimulating activity)]. Ann Pharm Fr 1983 0.75
30 [A method for counting mastocytes in rat peritoneal lavage fluid]. Ann Pharm Fr 1977 0.75
31 [Comparative study of heparin and histamine release by mast cells using lipid suspensions (author's transl)]. Ann Pharm Fr 1982 0.75
32 [Study of disodium cromoglycate action on mast cell degranulation and on heparin release induced by lipid suspension]. Ann Pharm Fr 1982 0.75
33 [Heparin release in patients after infusion of lipid suspensions. Measurement of heparinemia (author's transl)]. Ann Pharm Fr 1979 0.75
34 [Study of concomitant cell changes in peritoneal fluid colony stimulating factor release (author's transl)]. Ann Pharm Fr 1982 0.75
35 A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity. Mutat Res 1995 0.75
36 Soluble CD23 increases IL-3 induction of histamine synthesis by human bone marrow cells. Int Arch Allergy Appl Immunol 1991 0.75
37 Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activity. Leuk Res 1996 0.75
38 Ketorolac and enoxaparin affect arterial thrombosis and bleeding in the rabbit. Anesthesiology 1998 0.75
39 [Scanning electron microscopy study of the degranulation of peritoneal mast cells by compound 48/80]. Ann Pharm Fr 1984 0.75
40 Investigation of the effects of 50 Hz magnetic fields on purified human hematopoietic progenitors. Life Sci 1997 0.75
41 [Effect of increasing doses of dopamine on the left ventricular function in the dog]. Ann Anesthesiol Fr 1975 0.75
42 [Disparity of in vitro behavior of mastocytes under the effects of two lipid suspensions differing by their content in unsaturated fatty acids (author's transl)]. Ann Pharm Fr 1979 0.75
43 Inhibitory effect of new imidazole derivatives on the proliferation and nucleic acid synthesis of leukemic cells. Cytotechnology 1991 0.75
44 [Morphologic and cytochemical study of rat peritoneal fluid cells]. Ann Pharm Fr 1977 0.75
45 Interleukin 4 inhibits the proliferation and promotes the maturation of human leukemic early B cells. Eur J Haematol 1993 0.75
46 [Effects of prostaglandin E1 on mastocyte degranulation and heparin liberation elicited by lipid suspensions (author's transl)]. Ann Pharm Fr 1980 0.75
47 [In vitro study of mastocyte degranulation and heparin liberation elicited by lipid suspensions (author's transl)]. Ann Pharm Fr 1978 0.75
48 [The action of various antiadrenergic substances on the liberation of the growth factor (CSA) for granulo-monocytic lines]. Ann Pharm Fr 1983 0.75
49 [Culture of murine mastocytes: heterogeneity of the ultrastructural aspects]. C R Seances Soc Biol Fil 1986 0.75
50 A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance. Leuk Res 1998 0.75
51 Absence of the effects of 50 Hz magnetic fields on the progression of acute myeloid leukaemia in rats. Int J Radiat Biol 2000 0.75
52 Characterisation of enkephalinase (EC 3.4.24.11) activity on various leukemic cells expressing the common acute lymphocytic leukemia antigen (CALLA). FEBS Lett 1989 0.75
53 [Scanning electron microscopy study of the morphologic effects of the peritoneal margination of mast cells]. Ann Pharm Fr 1983 0.75
54 Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activity. Leuk Res 1991 0.75
55 Can 50 Hz magnetic fields alter iron metabolism and induce anaemia? Int J Radiat Biol 2000 0.75
56 [In vitro study of the action of human sera as a function of their lipid content on mastocyte degranulation and heparin release (author's transl)]. Ann Pharm Fr 1979 0.75
57 [Effects of adenosine-monophosphate 3'5' (AMPc) and guanosine monophosphate 3'5' (GMPc) upon the degranulation of mastocytes and heparin release induced by lipid suspensions (author's transl)]. Ann Pharm Fr 1979 0.75
58 Effect of retinoic acid on the proliferation and tumorigenicity of mouse mastocytoma cells : Effect of retinoic acid on mastocytoma cells. Cytotechnology 1989 0.75
59 [Recommendations for setting up and using point of care blood gas systems]. Ann Biol Clin (Paris) 2001 0.75
60 [Potentiation by anti-theta antilymphocyte gamma globulins of the action of endotoxin on CSA (colony-stimulating activity) release in the peritoneal fluid of mice]. Ann Pharm Fr 1982 0.75
61 [Determination of total nitrogen in biological milieux by chemoluminescence: a comparison with the reference method]. Ann Biol Clin (Paris) 1985 0.75
62 [Effect of retinoic acid on the differentiation and growth of murine mastocyte precursors]. C R Seances Soc Biol Fil 1988 0.75
63 [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)]. C R Seances Soc Biol Fil 1992 0.75
64 Cardiac troponin I cutoff values to predict postoperative cardiac complications after circulatory arrest and profound hypothermia. J Cardiothorac Vasc Anesth 1999 0.75
65 [Testing for enzymic involvement during mastocyte degranulation under the effect of lipid suspensions (author's transl)]. Ann Pharm Fr 1980 0.75